UPDATE : Monday, August 19, 2019
Access Bio, PFSCM sign supply agreement for malaria kit
Access Bio said Friday that it has signed a supply agreement of partnership...
by Lee Han-soo  |  2017-09-15 14:52
‘BIOplus Incheon 2017’ shares product-developing know-how
BIOplus Incheon 2017 successfully finished their second annual global confe...
by Lee Han-soo  |  2017-09-14 11:14
Medipost to commercialize new stem cell-culture tech
Medipost announced Wednesday that it has acquired a domestic patent for com...
by Constance Williams  |  2017-09-14 10:38
Hanall Biopharma made $81-million technology export to China
Hanall Biopharma said Tuesday it has licensed out two new bio drugs under d...
by Lee Hye-seon  |  2017-09-13 13:23
New VC investments in bio, medical fields fall sharpest in H1
New venture capital investments in bio and medical industries have fallen m...
by Nam Doo-hyun  |  2017-09-13 13:23
Celltrion presents Herzuma’s clinical results in Europe
Celltrion said Friday that it has presented the results of the clinical saf...
by Lee Han-soo  |  2017-09-11 12:19
Kang Stem, Heraeus Medical to develop anti-arthritis drug
Kang Stem Biotech 강스템바이오텍 said Thursday that it has signed an agreement wit...
by Lee Han-soo  |  2017-09-08 15:25
Pharma Research Product releases home care cosmetics
Pharma Research Products 파마리서치프로덕트, a regenerative medicine company, said T...
by Lee Han-soo  |  2017-09-07 17:08
Cellivery gets research funding from US Foundation
Cellivery, a protein-based drug discovery/development company, said Thursda...
by Lee Han-soo  |  2017-09-07 15:00
Abclon confirms IPO at 10,000 won per share
Abclon, a biotechnology company, said Wednesday that it has confirmed its i...
by Lee Han-soo  |  2017-09-07 11:48
Papers related to stem cell therapy rising worldwide
Seoul National University서울대학교, Catholic University of Korea가톨릭대학교, and Sch...
by Nam Doo-hyun  |  2017-09-06 16:45
Wells Bio wins rights to make and sell ‘Strep A Plus’
Wells Bio 웰스바이오 said Tuesday it has obtained domestic manufacturing and sal...
by Lee Han-soo  |  2017-09-06 11:48
Samsung Bioepis wins European sales approval for Imraldi
The European Commission (EC) has granted marketing authorization for Samsun...
by Lee Han-soo  |  2017-08-25 11:53
Bio firms blame small R&D spending for low technology
Korea’s bio businesses cite “lack of R&D investment” as the main reason for...
by Nam Doo-hyun  |  2017-08-24 11:31
Celltrion’s move to main stock market draws investor concern
The recent decision by Celltrion, Korea’s most successful biosimilar maker,...
by Nam Doo-hyun  |  2017-08-22 17:01
Samsung Bioepis, Takeda agree to develop biosimilar drugs
Samsung Bioepis and Takeda Pharmaceutical have signed a strategic collabora...
by Lee Han-soo  |  2017-08-21 20:45
iNtRON Biotechnology adds trial for super bacteria drug
iNtRON Biotechnology has gained approval to start an additional Phase 1b cl...
by Marian Chu  |  2017-08-21 16:15
Korea lags 3.8 years behind US in medical technology
There are technological gaps of 3.8 years in the medical area and 4.3 years...
by Nam Doo-hyun  |  2017-08-21 12:11
‘Bio industry should prepare for Nagoya Protocol’
As the Nagoya Protocol, an international agreement on using foreign biologi...
by Nam Doo-hyun  |  2017-08-17 19:57
Monsanto, ToolGen sign licensing agreement for CRISPR
ToolGen툴젠, a local genome engineering company, has signed a global license ...
by Constance Williams  |  2017-08-17 16:32
Back to Top